Clovis Oncology Inc. buy Traumtanz
Start price
29.01.21
/
70%
€6.91
Target price
€8.00
Performance (%)
16.27%
End price
06.02.21
€8.03
Summary
This prediction ended on 06.02.21 with a price of €8.03. The prediction had a final performance of 16.27%. Traumtanz has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Clovis Oncology Inc. | - | - | - | - |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% | 68.786% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% | 100.066% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% | 43.024% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% | 63.222% |
According to Traumtanz what are the pros and cons of Clovis Oncology Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Traumtanz for this prediction
In the thread Clovis Oncology Inc. diskutieren
